| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 4.5 | 4.0 | 3.1 |
| Other income | 0.3 | 0.0 | 0.1 |
| Total income | 4.8 | 4.0 | 3.2 |
| Profit before exceptional items & tax | -0.5 | -0.2 | 0.0 |
| Profit before tax | -0.5 | -0.2 | 0.0 |
| Net profit | -0.5 | -0.2 | 0.0 |
| Operating margin | -10.4% | -5.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +45.20% |
|---|
BSE results filing, BSE: 544312. Figures extracted from the filing.
Hamps Bio Ltd: key numbers
- Share price
- ₹22.51
- Market cap
- ₹19.61 Cr
- Revenue (annual)
- ₹8.47 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -26.6×Sector 29.0×
- Promoter holding
- 71.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hamps Bio Ltd
All →Hamps Bio Board Meeting Outcome
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Annual General Meeting
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.